The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

Matthew A Roberts; Helen L Pilmore; Francesco L Ierino; Sunil V Badve; Alan Cass; Amit X Garg; Carmel M Hawley; Nicole M Isbel; Henry Krum; Elaine M Pascoe; Andrew M Tonkin; Liza A Vergara; Vlado Perkovic

Journal article

The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

Matthew A Roberts, Helen L Pilmore, Francesco L Ierino, Sunil V Badve, Alan Cass, Amit X Garg, Carmel M Hawley, Nicole M Isbel, Henry Krum, Elaine M Pascoe, Andrew M Tonkin, Liza A Vergara, Vlado Perkovic

Nephrology | WILEY | Published : 2015

DOI: 10.1111/nep.12362

University of Melbourne Researchers

Francesco Ierino Author Medicine - St Vincent's Hospital

Related Projects (1)

The BLOCADE Feasibility Study

The BLOCADE Feasibility Study aims to find out what is needed for a study to see if the drug carvedilol reduces heart disease events in peop..

Grants

Awarded by New Zealand Health Research Council Feasibility Study Grant

Awarded by National Health and Medical Research Council (NHMRC) Project Grant

Awarded by NHMRC Training Fellowship

Funding Acknowledgements

The BLOCADE Feasibility Study acknowledges the following funding sources: Don & Lorraine Jacquot Collaborative Research Initiative Grant (2008), the New Zealand Health Research Council Feasibility Study Grant (10-163), the National Health and Medical Research Council (NHMRC) Project Grant (1006171) and Pfizer CVL (2008). Roche Products, Pty Limited provided Dilatrend(R) at a discounted price. In addition, MAR was supported by an NHMRC Training Fellowship (628902).